Adult classical homocystinuria requiring parenteral nutrition: Pitfalls and management.

Détails

ID Serval
serval:BIB_FB321D4C385F
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Adult classical homocystinuria requiring parenteral nutrition: Pitfalls and management.
Périodique
Clinical nutrition
Auteur⸱e⸱s
Tran C., Bonafé L., Nuoffer J.M., Rieger J., Berger M.M.
ISSN
1532-1983 (Electronic)
ISSN-L
0261-5614
Statut éditorial
Publié
Date de publication
08/2018
Peer-reviewed
Oui
Volume
37
Numéro
4
Pages
1114-1120
Langue
anglais
Notes
Publication types: Journal Article ; Review
Publication Status: ppublish
Résumé
Homocystinuria due to cystathionine beta synthase (CBS) deficiency presents with a wide clinical spectrum. Treatment by the enteral route aims at reducing homocysteine levels by using vitamin B6, possibly methionine-restricted diet, betaine and/or folate and vitamin B <sub>12</sub> supplementation. Currently no nutritional guidelines exist regarding parenteral nutrition (PN) under acute conditions.
Exhaustive literature search was performed, in order to identify the relevant studies describing the pathogenesis and nutritional intervention of adult classical homocystinuria requiring PN. Description of an illustrative case of an adult female with CBS deficiency and intestinal perforation, who required total PN due to contraindication to enteral nutrition.
Nutritional management of decompensated classical homocystinuria is complex and currently no recommendation exists regarding PN composition. Amino acid profile and monitoring of total homocysteine concentration are the main tools enabling a precise assessment of the severity of metabolic alterations. In case of contraindication to enteral nutrition, compounded PN will be required, as described in this paper, to ensure adequate low amounts of methionine and others essential amino acids and avoid potentially fatal toxic hypermethioninemia.
By reviewing the literature and reporting successful nutritional management of a decompensated CBS deficiency using tailored PN with limited methionine intake and n-3 PUFA addition, we would like to underscore the fact that standard PN solutions are not adapted for CBS deficient critical ill patients: new solutions are required. High methionine levels (>800 μmol/L) being potentially neurotoxic, there is an urgent need to improve our knowledge of acute nutritional therapy.
Mots-clé
Homocystinuria/therapy, Humans, Parenteral Nutrition, Practice Guidelines as Topic, Copper deficiency, Critical care, Glutamine, Inflammation, Methionine, n-3 PUFA
Pubmed
Web of science
Création de la notice
15/10/2017 13:29
Dernière modification de la notice
26/10/2019 6:09
Données d'usage